Published in J Antimicrob Chemother on December 01, 2002
Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital. Br J Clin Pharmacol (2006) 1.18
Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures. Arch Ophthalmol (2011) 1.11
Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape. Genome Biol Evol (2014) 0.98
In vitro antibacterial activity of modithromycin, a novel 6,11-bridged bicyclolide, against respiratory pathogens, including macrolide-resistant Gram-positive cocci. Antimicrob Agents Chemother (2011) 0.90
Nasopharyngeal Carriage, Antibiotic Resistance and Serotype Distribution of Streptococcus Pneumoniae among Healthy Adolescents in Zahedan. Iran Red Crescent Med J (2011) 0.90
Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece. BMC Infect Dis (2009) 0.89
Connection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob Agents Chemother (2008) 0.89
Antimicrobial resistance trends among community-acquired respiratory tract pathogens in Greece, 2009-2012. ScientificWorldJournal (2014) 0.86
Increasing penicillin and trimethoprim-sulfamethoxazole resistance in nasopharyngeal Streptococcus pneumoniae isolates from Guatemalan children, 2001--2006. Int J Infect Dis (2007) 0.80
Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal. Epidemiol Infect (2007) 0.80
Knowledge, attitudes, perceptions and habits towards antibiotics dispensed without medical prescription: a qualitative study of Spanish pharmacists. BMJ Open (2017) 0.75
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science (2000) 9.14
Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis (2007) 4.51
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect (2010) 4.07
Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain. Antimicrob Agents Chemother (2001) 2.91
EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect (2011) 2.65
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42
Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC. Antimicrob Agents Chemother (1996) 2.07
Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg). Int J Oral Maxillofac Surg (2007) 1.76
Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis (2000) 1.74
Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob Agents Chemother (2005) 1.73
Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J Antimicrob Chemother (2000) 1.72
Applications of flow cytometry to clinical microbiology. Clin Microbiol Rev (2000) 1.69
The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clin Microbiol Infect (2012) 1.53
[Vibrio alginolyticus and swimmer's otitis externa. 2 cases and review of the literature]. Enferm Infecc Microbiol Clin (1991) 1.44
In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates. Int J Antimicrob Agents (2006) 1.42
Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. J Infect Dis (1996) 1.29
Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains. Antimicrob Agents Chemother (2001) 1.24
Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999. Antimicrob Agents Chemother (2001) 1.22
Soft salt-mannitol agar-cloxacillin test: a highly specific bedside screening test for detection of colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1998) 1.22
Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones. Antimicrob Agents Chemother (2001) 1.18
Characterization of a nosocomial outbreak involving an epidemic plasmid encoding for TEM-27 in Salmonella enterica subspecies enterica serotype Othmarschen. J Infect Dis (1996) 1.17
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. Antimicrob Agents Chemother (1999) 1.11
In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens. J Antimicrob Chemother (1996) 1.10
Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients. Clin Microbiol Infect (2010) 1.10
Beta-lactam stability in frozen microdilution PASCO MIC panels using strains with known resistance mechanisms as biosensors. Diagn Microbiol Infect Dis (1996) 1.09
Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in Spain. Antimicrob Agents Chemother (2000) 1.08
Clinical and microbiological features of a cystic fibrosis patient chronically colonized with Pandoraea sputorum identified by combining 16S rRNA sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2011) 1.08
Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimioter (2007) 1.07
Carbapenem Heteroresistance in VIM-1-producing Klebsiella pneumoniae isolates belonging to the same clone: consequences for routine susceptibility testing. J Clin Microbiol (2010) 1.06
Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998. Emerg Infect Dis (2001) 1.04
Nontuberculous mycobacteria in patients with cystic fibrosis. Clin Infect Dis (2001) 1.03
A novel flow cytometric assay for rapid detection of extended-spectrum beta-lactamases. Clin Microbiol Infect (2012) 1.02
Genetic and phenotypic differences among Enterococcus faecalis clones from intestinal colonisation and invasive disease. Clin Microbiol Infect (2006) 1.01
Non-diphtheriae Corynebacterium species: an emerging respiratory pathogen. Eur J Clin Microbiol Infect Dis (2012) 1.00
Application of a Spanish version of the "Informant Questionnaire on Cognitive Decline in the Elderly" in the clinical assessment of dementia. Alzheimer Dis Assoc Disord (1997) 1.00
The E-Test as an epidemiologic tool. Diagn Microbiol Infect Dis (1992) 0.99
Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes. Antimicrob Agents Chemother (1999) 0.99
Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol (1998) 0.99
In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms. Antimicrob Agents Chemother (2001) 0.98
[Criteria of the MENSURA group for the definition of the critical points of sensitivity to antibiotics]. Enferm Infecc Microbiol Clin (1998) 0.98
Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect (2008) 0.96
Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial. Clin Microbiol Infect (2008) 0.95
Performance of the VITEK2 system for identification and susceptibility testing of routine Enterobacteriaceae clinical isolates. Int J Antimicrob Agents (2001) 0.95
Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care (1998) 0.93
Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. Pediatr Pulmonol (1998) 0.93
Comparative in vitro activity of clarithromycin. Spanish Collaborative Group. Eur J Clin Microbiol Infect Dis (1992) 0.91
Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori. Scand J Gastroenterol (1997) 0.91
Clinical and epidemiological characterization of a lymphogranuloma venereum outbreak in Madrid, Spain: co-circulation of two variants. Clin Microbiol Infect (2013) 0.90
Prevalence of extended-spectrum beta-lactamases in group-1 beta-lactamase-producing isolates. Clin Microbiol Infect (2001) 0.88
Emergence of CTX-M beta-lactamase-producing Enterobacteriaceae in Portugal: report of an Escherichia coli isolate harbouring blaCTX-M-14. Clin Microbiol Infect (2004) 0.88
Activities of six different quinolones against clinical respiratory isolates of Streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain. Antimicrob Agents Chemother (2002) 0.87
Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus. Diabetes Res Clin Pract (2001) 0.87
Prestroke dementia. Cerebrovasc Dis (2001) 0.87
Molecular analysis of community-acquired methicillin-susceptible and resistant Staphylococcus aureus isolates recovered from bacteraemic and osteomyelitis infections in children from Tunisia. Clin Microbiol Infect (2010) 0.86
MALDI-TOF mass spectrometry as a tool for the discrimination of high-risk Escherichia coli clones from phylogenetic groups B2 (ST131) and D (ST69, ST405, ST393). Eur J Clin Microbiol Infect Dis (2014) 0.86
[Escherichia vulneris infection. Report of 2 cases]. Enferm Infecc Microbiol Clin (1993) 0.85
Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009). Clin Microbiol Infect (2011) 0.85
Laboratory and in-vitro testing of skin antiseptics: a prediction for in-vivo activity? J Hosp Infect (1991) 0.85
Evaluation of the OSIRIS video reader system for disk diffusion susceptibility test reading. Clin Microbiol Infect (2001) 0.84
Concordance between noninvasive tests in detecting Helicobacter pylori and potential use of serology for monitoring eradication in gastric ulcer. J Clin Gastroenterol (2000) 0.84
Antimicrobial resistance in recent fecal enterococci from healthy volunteers and food handlers in Spain: genes and phenotypes. Microb Drug Resist (2003) 0.84
High-density fecal Enterococcus faecium colonization in hospitalized patients is associated with the presence of the polyclonal subcluster CC17. Eur J Clin Microbiol Infect Dis (2011) 0.83
Spontaneous bacterial peritonitis caused by Listeria monocytogenes: two case reports and literature review. Eur J Clin Microbiol Infect Dis (1992) 0.82
Nosocomial and community-acquired meticillin-resistant Staphylococcus aureus infections in hospitalized patients (Spain, 1993-2003). J Hosp Infect (2006) 0.82
Usefulness of the combined IgG and IgA antibody determinations for serodiagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1997) 0.82
Comparative in vitro activity of quinolones against Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis (1999) 0.82
Public health microbiology, a challenge for Europe. Clin Microbiol Infect (2009) 0.82
Assessment of virulence factors characteristic of human Escherichia coli pathotypes and antimicrobial resistance in O157:H7 and non-O157:H7 isolates from livestock in Spain. Appl Environ Microbiol (2013) 0.81
High seroprevalence of Helicobacter pylori infection in coronary heart disease. Lancet (1995) 0.81
Clinical variables associated with the isolation of Klebsiella pneumoniae expressing different extended-spectrum beta-lactamases. Clin Microbiol Infect (2007) 0.80
Genetic relatedness of recently collected Spanish respiratory tract Streptococcus pneumoniae isolates with reduced susceptibility to amoxicillin. Antimicrob Agents Chemother (2003) 0.80
Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients. Clin Microbiol Infect (2011) 0.80
[Is there any association between Helicobacter pylori infection and peptic esophagitis?]. Med Clin (Barc) (1995) 0.80
[in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases]. Enferm Infecc Microbiol Clin (1997) 0.80
Neuromuscular disorders in a new toxic syndrome: electrophysiological study--a preliminary report. Muscle Nerve (1984) 0.80
[Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study]. Rev Esp Quimioter (2010) 0.79
[Comparison of the microdilution method (PASCO), the Etest and disc-diffusion in streptococcus pneumoniae antibiotic susceptibility testing]. Rev Esp Quimioter (1998) 0.78
Lack of usefulness of the immunochromatographic urinary pneumococcal antigen test in maximizing pneumococcal yield in a community-acquired pneumonia clinical trial. J Chemother (2006) 0.78
Helicobacter pylori infection with parietal cell antibodies in children and adolescents with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab (1998) 0.77
[Molecular basis of resistance to beta-lactams in infections by Streptococcus pneumoniae]. Med Clin (Barc) (1998) 0.77
Cystic fibrosis: deciphering the complexity. Clin Microbiol Infect (2010) 0.77
Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones. Clin Microbiol Infect (2006) 0.77
ABO blood groups, rhesus factor and Helicobacter pylori. Rev Esp Enferm Dig (1998) 0.77
Amphetamine and chlorpromazine modify cerebral insulin levels in rats. Life Sci (1988) 0.76
[Helicobacter pylori infection and basal levels of serum gastrins in patients with duodenal ulcer and subjects with normal endoscopy]. Med Clin (Barc) (1996) 0.76
[Comparative in vitro activity of ertapenem against aerobic and anaerobic bacteria]. Rev Esp Quimioter (2003) 0.76
In vitro activity of Ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria. Antimicrob Agents Chemother (2013) 0.75
Galenic formulations and Helicobacter pylori eradication. Scand J Gastroenterol (1996) 0.75
Helicobacter pylori infection in a healthy population in Spain. Eur J Gastroenterol Hepatol (1996) 0.75
[Cerebrovascular accident in young adults. A study of 52 cases]. Rev Neurol (1996) 0.75
[A decrease in the basal levels of serum pepsinogen I after H. pylori eradication]. Rev Clin Esp (1995) 0.75
[Helicobacter pylori, gastric ulcer and non-steroidal anti-inflammatory agents]. Med Clin (Barc) (1996) 0.75
Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms. Clin Microbiol Infect (2012) 0.75
[Intracranial hypotension and sixth cranial nerve palsy]. Neurologia (1995) 0.75
Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission. Eur J Clin Microbiol Infect Dis (2012) 0.75
Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin. Eur J Clin Microbiol Infect Dis (1995) 0.75
[H. pylori infection at the duodenal bulb in different endoscopic diagnoses]. Rev Clin Esp (1995) 0.75
[Intracranial tuberculomas in an immunocompetent patient]. Rev Neurol (2000) 0.75
[Prevalence of Helicobacter pylori infection in gastric adenocarcinoma and chronic gastritis]. Rev Esp Enferm Dig (1996) 0.75
Fluconazole-containing agar Sabouraud dextrose plates are not useful when screening for susceptibility in Candida albicans. Rev Esp Quimioter (2017) 0.75